This research proposal will examine the fundamental mechanisms responsible for the critical clinical problem of hepatic growth. The authors have had extensive experience in the development of several animal models which are ideal for the in depth study of hepatic regeneration, and propose to use these models in a rigorous and complementary fashion to attempt to study the mechanisms, regarding control of hepatic regeneration in both normal and cirrhotic liver. The hypotheses to be tested include: 1) Administration of so-called hepatotropic factors, such as insulin, glucagon, epidermal growth factor (EGF), and transforming growth factor alpha (TGF-alpha) stimulate liver regeneration of cirrhotic rats in vivo. 2) Significant alterations in peptide binding occur in plasma membranes from regenerating and cirrhotic liver, and are responsible, in part for the decreased proliferative response seen in cirrhosis; 3) Antiproliferative factors, such as somatostatin-14 (SS-14) and transforming growth factor beta (TGF-beta) inhibit hepatic proliferation by direct action on second messenger pathways in rat hepatocytes, which can be mimicked by specific pharmacologic probes. Specifically dideoxyadenosine (DDA) (an inhibitor of the catalytic subunit of adenylyl cyclase) and other pharmacologic reagents may mimic the action of SS-14, and alter intracellular accumulation of cyclic AMP; 4) Signaling mechanisms of GI peptide receptors for hepatic proliferation are linked to G proteins, and alterations of G protein structure and function occur during cirrhosis; 5) Altered patterns of early gene expression exist in cirrhosis which are responsible for the attenuated proliferative response;
The specific aims of this proposal will be: 1) To attempt to increase hepatic regeneration in cirrhotic rats by the administration of exogenous growth factors. 2) To study the effect of hepatic regeneration and cirrhosis on the binding of EGF, TGF-alpha, insulin, glucagon, SS-14, and TGF-beta to liver plasma membranes; 3) To compare the antiproliferative effects of pharmacologic probes - which may mimic exogenous peptides - of the adenylyl cyclase system on hepatocytes from quiescent and hepatectomized normal and cirrhotic rat liver; 4) To determine the role of G-proteins in signal transduction pathways leading to hepatocyte proliferation, and to compare G proteins in normal liver to those found in cirrhotic liver; 5) To study the effects of hepatectomy and cirrhosis on the expression of immediate early response genes which are known to play a role in hepatic regeneration. The models utilized to accomplish the specific aims include 1) hepatotropic factor stimulation of the sham hepatectomized rat with analysis of plasma membrane binding, second messenger analysis, structural G-protein studies, early gene regulation, and analysis of hepatic DNA synthesis; 2) 70% hepatectomy and biochemical and molecular analysis as described above; 30 the Wistar cirrhotic rat model; 4) isolated cultured hepatocyte preparations; 5) highly purified subcellular fractions, including isolated liver plasma membrane preparations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK047811-03
Application #
2147675
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1993-07-01
Project End
1997-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Surgery
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Raper, Steven E; McClane, Steven J (2002) Gene transfer strategies for metabolic diseases. World J Surg 26:838-42
Nunes, F A; Furth, E E; Wilson, J M et al. (1999) Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration. Hum Gene Ther 10:2515-26
Burke, C V; Buettger, C W; Davis, E A et al. (1999) Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI). Biochem J 342 ( Pt 2):345-52
Hashimoto, M; Kothary, P C; Raper, S E (1999) Phenobarbital in comparison with carbon tetrachloride and phenobarbital-induced cirrhosis in rat liver regeneration. J Surg Res 81:164-9
Hashimoto, M; Kothary, P C; Eckhauser, F E et al. (1998) Treatment of cirrhotic rats with epidermal growth factor and insulin accelerates liver DNA synthesis after partial hepatectomy. J Gastroenterol Hepatol 13:1259-65
Raper, S; Kothary, P; Ishoo, E et al. (1995) Divergent mechanisms of insulin-like growth factor I and II on rat hepatocyte proliferation. Regul Pept 58:55-62
Bhora, F Y; Kothary, P C; Imanishi, H et al. (1994) Vasopressin stimulates DNA synthesis in cultured rat hepatocytes. J Surg Res 57:706-10